Precision Cardiology Market
Precision Cardiology Market Scope: Industry
Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
Precision Cardiology Market Size and Growth
The Precision Cardiology market is experiencing significant growth, driven by advancements in genomics and personalized healthcare. Currently valued at approximately $2.5 billion, the market is projected to expand at a CAGR of 10% over the next five years, reflecting increased investment in precision medicine and tailored treatment approaches for cardiovascular diseases.
Companies Covered
(Covid 19 Impact Covered)
◍ ARUP Laboratories
◍ CENTOGENE N.V.
◍ Eurofins Scientific
◍ Exact Sciences Corporation
◍ Fulgent Genetics Inc.
◍ Illumina Inc.
◍ Thermo Fisher Scientific Inc.
◍ Abbott Laboratories
◍ GENinCode
◍ DNA Genotek Inc.
The Precision Cardiology Market features key players like ARUP Laboratories, CENTOGENE N.V., and Illumina, focusing on genetic testing and biomarker analysis to tailor cardiovascular treatments. Companies utilize advanced diagnostics to enhance patient outcomes, driving market growth. Notable revenues include:
- Illumina: ~$4.5 billion
- Abbott Laboratories: ~$43 billion
- Exact Sciences: ~$1.2 billion
Request Sample Report
Market Segmentation
By Application
By Product
Product ◍ Cardiomyopathy
◍ Arrhythmia
◍ Aortopathy and Vascular Diseases
◍ Familial Hypercholesterolemia
◍ Congenital Heart Defects and Syndromes
Request Sample Report
Service
Market Growth
Request Sample Report
$ X Billion USD
